In a recent interview with BC Cancer Research, Dr. Martin Hirst, Senior Scientist at Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC), discusses the details of a multi-partner COVID-19 research project involving BC Cancer, the University of British Columbia, and the British Columbia Centre for Disease Control. Dr. Hirst highlights how STEMCELL Technologies is helping to formulate and scale reagents to support the project goals for rapid diagnostic testing.

Read More >

Image source: BC Cancer